Autolus Therapeutics Ltd (AUTL) support and resistance · rev $71.9M
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
This page maps Autolus Therapeutics Ltd (AUTL) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
AUTL currently screens at market cap $614.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new AUTL 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the AUTL quote page for the session range and the stock page for the full model.
Not investment advice.